AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2021
Jun 30, 2021
29745_dirs_2021-06-30_5dd86a61-ea58-445d-9f38-d4f4ae5297ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-06-27
Reporting Person: Weems Alonzo (SVP, ERM & CECO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5061 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2023-03-01 | Common Stock (1779.0) | Direct | |
| Restricted Stock Unit | $ | 2024-11-01 | Common Stock (1687.0) | Direct | |
| Restricted Stock Unit | $ | 2025-03-01 | Common Stock (2669.0) | Direct | |
| Restricted Stock Unit | $ | 2026-11-01 | Common Stock (2530.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 11
Prospectus
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Prospectus
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 20